It contains the same active ingredient as Ozempic and Wegovy semaglutide and studies show it is about as effective as the injections when it comes to weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 49.de Vries AP, et al
Insurance Coverage and Prescribing Guidelines GLP-1 medications such as Ozempic, Wegovy, and Mounjaro are now approved for long-term use in maintaining weight loss after an initial reduction phase
They are expressed throughout the central nervous system, including in brain regions that regulate reward, motivation, and pleasure
Just because these medications dont increase psychiatric risk at the population level doesnt mean we stop monitoring individual patients
Microdosing as a GI management strategy Some researchers use an even more gradual approach, essentially micro-titrating by splitting doses or starting below the standard initial dose